Real-World Characteristics, Treatment Patterns, Healthcare Resource Use and Costs of Patients with Diffuse Large B-Cell Lymphoma in the United States

CONCLUSION: This study showed that a large portion of patients require additional therapy after 1L treatment to manage DLBCL, and highlighted the substantial economic burden of DLBCL patients, particularly within the first year following diagnosis.PMID:33616256 | DOI:10.1002/onco.13721

Source: The Oncologist - February 22, 2021 Category: Cancer & Oncology Authors: Xiaoqin Yang Fran çois Laliberté Guillaume Germain Monika Raut Mei Sheng Duh Shuvayu S Sen Dominique Lejeune Kaushal Desai Philippe Armand Source Type: research